Indirect comparisons of ranibizumab and dexamethasone in macular oedema secondary to retinal vein occlusion - Wikidata - wikimedia - TriplyDB

Indirect comparisons of ranibizumab and dexamethasone in macular oedema secondary to retinal vein occlusion

Indirect comparisons of ranibizumab and dexamethasone in macular oedema secondary to retinal vein occlusion

http://www.wikidata.org/entity/Q34901208

about

Steroids in Central Retinal Vein Occlusion: Is There a Role in Current Treatment Practice?Central retinal vein occlusion: modifying current treatment protocols.Treatment patterns of ranibizumab intravitreal injection and dexamethasone intravitreal implant for retinal vein occlusion in the USA.Comparison between "early" or "late" intravitreal injection of dexamethasone implant in branch (BRVO) or central (CRVO) retinal vein occlusion: six-months follow-up.Predicting the visual acuity for retinal vein occlusion after ranibizumab therapy with an original ranking for macular microstructure.Low frequency ranibizumab versus dexamethasone implant for macular oedema secondary to branch retinal vein occlusion.

P2860

Q26774524-A527B7C6-6165-4187-91C5-9108DBECC0C3 Q35921621-EB76D9AF-964A-4BF5-B095-66393EB16A91 Q39136236-38F0633C-AB28-44E6-85A3-463CBEF609AC Q40429268-C446081B-736C-4F4F-88A9-F138C87384BF Q49232014-8EA54DB3-B0F0-486C-B13D-F236C5913EF9 Q50042514-744C1691-5679-43BA-A12B-3AFC62BAF9B6

P2860

Indirect comparisons of ranibizumab and dexamethasone in macular oedema secondary to retinal vein occlusion

http://www.wikidata.org/entity/Q34901208

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Indirect comparisons of ranibi ...... dary to retinal vein occlusion

@ast

Indirect comparisons of ranibi ...... dary to retinal vein occlusion

@en

Indirect comparisons of ranibi ...... dary to retinal vein occlusion

@nl

type

label

Indirect comparisons of ranibi ...... dary to retinal vein occlusion

@ast

Indirect comparisons of ranibi ...... dary to retinal vein occlusion

@en

Indirect comparisons of ranibi ...... dary to retinal vein occlusion

@nl

prefLabel

Indirect comparisons of ranibi ...... dary to retinal vein occlusion

@ast

Indirect comparisons of ranibi ...... dary to retinal vein occlusion

@en

Indirect comparisons of ranibi ...... dary to retinal vein occlusion

@nl

P1433

Q34901208-A7F02331-2178-4308-9D41-1FC037D6B630

P1476

Q34901208-89A9DDC1-7F60-4895-8815-0E3BE98555E3

P2093

Q34901208-18D968FD-CDBB-4D1B-BE2C-2D286613FFE9

Q34901208-512F2FEE-B742-4B82-ADBA-BAD00262010E

Q34901208-65DC8E88-2BBF-4DE4-AF82-9D5A2309F32F

Q34901208-847A0992-4FEF-44D2-9D07-DD97AA3EF4F1

P2860

Q34901208-004B68EC-CFA7-4FC3-95B0-B9DBD80FA085

Q34901208-11F98013-025E-4119-9A53-1377F44B1681

Q34901208-18B2E3BB-2D05-4DA6-9CCC-F8B2C38806F2

Q34901208-1AC6A7D3-0081-47D0-A9CD-6A5DD5237DDD

Q34901208-20E658EB-B23E-463E-A564-5D05452E8587

Q34901208-3BBCDA8E-C1DF-40E9-B944-224F8B6718F3

Q34901208-4278F014-D48B-482C-971E-433D9B8E67BE

Q34901208-44CEFDA8-9C26-41A4-9004-71D6F7921264

Q34901208-5EA158A5-E4F6-40DA-A1A6-7F498EEC53C3

Q34901208-6CBCB414-13B3-4742-901F-1E7A6760FDFE

P2888

Q34901208-CC0F769C-1532-4C38-B766-9B7E3D840114

P304

Q34901208-034205C9-2EAE-43B4-A72E-D7053643BA04

P31

Q34901208-8E2EAE78-EC8C-47C2-913C-79418BC08FD4

P356

Q34901208-77239B01-EEF6-431F-B6BC-960456E4BE38

P478

Q34901208-CDD53F2F-DE6A-4B55-ADB7-50920BCE18A8

P577

Q34901208-7218C4C5-069B-48FB-8908-05FD45471BAB

P5875

Q34901208-269EDD60-C28C-4069-A086-313A7F922D2A

P6179

Q34901208-3EAAB387-3CC7-4E2B-B065-D11806FEE6B8

P698

Q34901208-5C767A9B-25A4-4684-B431-BF278359221B

P921

Q34901208-51F24D73-4D74-4B2A-AF70-FA777BDCE625

P932

Q34901208-1F87FB68-6E81-4EE7-9F84-6F177836C980

P356

1471-2288-14-140

P1433

BMC Medical Research Methodology

P1476

Indirect comparisons of ranibi ...... dary to retinal vein occlusion

@en

P2093

Alberto Ferreira

http://www.w3.org/2001/XMLSchema#string

Gorana Capkun

http://www.w3.org/2001/XMLSchema#string

Howard H Z Thom

http://www.w3.org/2001/XMLSchema#string

Richard M Nixon

http://www.w3.org/2001/XMLSchema#string

P2860

Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion

A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein

Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study

Combination of direct and indirect evidence in mixed treatment comparisons

The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials

What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data.

Interventions for central retinal vein occlusion: an evidence-based systematic review.

Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities

Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study.

Simultaneous comparison of multiple treatments: combining direct and indirect evidence.

P2888

1471-2288-14-140

P304

140

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2288-14-140

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2014-12-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

269999998

http://www.w3.org/2001/XMLSchema#string

P6179

1018296847

http://www.w3.org/2001/XMLSchema#string

P698

25533265

http://www.w3.org/2001/XMLSchema#string

P921

P932

4289570

http://www.w3.org/2001/XMLSchema#string